Vivus

Reimbursement battle for Qsymia hits Vivus figures
Pharma Times, UK
Tue, 02/26/13 - 10:55 am
Vivus
reimbursement
Qsymia
VIVUS Earnings: Here’s Why Investors are Not Excited Now
Wall St. Cheat Sheet
Tue, 02/26/13 - 10:33 am
earnings
Vivus
This Week in Biotech
Motley Fool
Sun, 02/24/13 - 02:20 pm
Roche
Immunogen
Repros Therapeutics
Chelsea Therapeutics
Gilead Sciences
Vivus
Vivus, Inc.: Second Rejection And Upcoming Earnings, Patience Required For Investors
Seeking Alpha
Fri, 02/22/13 - 11:37 am
Vivus
earnings
Qsymia
CHMP rejects Vivus diet pill again
Pharma Times, UK
Fri, 02/22/13 - 10:45 am
Vivus
Europe
Qsiva
Qsymia
This Obesity Bet Just Became More Attractive
Motley Fool
Wed, 02/13/13 - 10:43 am
obesity
Vivus
Pfizer
Qsymia
Arena Pharmaceuticals
Slow and steady can win the diet drug race: Vivus' launch of Belviq
Reuters
Fri, 02/8/13 - 11:17 am
Vivus
Belviq
obesity
drug launches
EnteroMedics: Fat Zapper or Pulsing Placebo?
TheStreet.com
Wed, 02/6/13 - 08:37 am
EnteroMedics
Vivus
Arena Pharmaceuticals
Vbloc
Vivus up on heart drug study
Investors Business Daily
Sat, 02/2/13 - 11:44 am
Vivus
Qsymia
Anti-Hypertension
Vivus Stock Up On Qsymia Heart Disease Study
Investors.com
Fri, 02/1/13 - 11:38 am
Vivus
Qsymia
The Obesity Epidemic: EnteroMedics' New Treatment Approach
Seeking Alpha
Tue, 01/29/13 - 11:09 am
obesity
EnteroMedics
Acadia
Vivus
Orexigen
Arena Pharmaceuticals
Which Biotech Company Will Be Bought Out Next?
Motley Fool
Sun, 01/27/13 - 11:18 am
Theravance
GSK
Astellas
Vivus
Eli Lilly
Immunogen
Roche
M&A
Vivus: Today's Featured Drugs Laggard
The Street
Sat, 01/26/13 - 11:45 am
Vivus
Which Biotech Company Will Be Bought Out Next?
Motley Fool
Fri, 01/25/13 - 10:40 am
Vivus
Theravance
Roche
MAP Pharmaceuticals
M&A
Immunogen
GSK
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Allergan
The Biggest Loser in the Obesity Drug Market
Motley Fool
Fri, 01/18/13 - 09:20 am
obesity
Vivus
Qsymia
Belviq
Arena Pharmaceuticals
Orexigen
Contrave
Will Qsymia's Stellar Sales Growth Continue?
Motley Fool
Fri, 01/11/13 - 12:15 pm
Vivus
Qsymia
obesity
4 Biotechnology Stocks With Upcoming Catalysts
Seeking Alpha
Wed, 01/9/13 - 10:06 am
Vivus
Peregrine Pharmaceuticals
JNJ
Cellceutix
Vivus obesity pill prescriptions jump 68 percent, shares rise
Reuters
Mon, 01/7/13 - 10:39 am
Vivus
obesity
Qsymia
Upcoming Catalysts For Vivus
Seeking Alpha
Fri, 01/4/13 - 11:41 am
Vivus
Qsymia
And the Obesity Plot Thickens
Motley Fool
Wed, 01/2/13 - 11:58 am
obesity
Vivus
Arena Pharmaceuticals
Roche
Orexigen
mimAb1
Amgen
Zafgen
Belviq
Qsymia
beloranib
Contrave

Pages